SEC Info - Cell MedX Corp. - ‘10-K’ for 5/31/18

SEC Info℠

Home

My Interests

Help

Please Sign In

Cell MedX Corp. – ‘10-K’ for 5/31/18 – ‘EX-101.PRE’

On: Thursday, 9/13/18, at 4:36pm ET · For: 5/31/18 · Accession #: 1393905-18-275 · File #: 0-54500

Previous ‘10-K’: ‘10-K’ on 8/29/17 for 5/31/17 · Next: ‘10-K’ on 9/6/19 for 5/31/19 · Latest: ‘10-K’ on 9/1/23 for 5/31/23 · 20 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    521K 
 7: EX-10.45    Loan Agreement and Note Payable Dated April 5,      HTML     32K 
                2018                                                             
 8: EX-10.46    Loan Agreement and Note Payable Dated May 8, 2018   HTML     32K 
 9: EX-10.47    Intellectual Property Royalty Agreement Dated for   HTML     45K 
                Reference September 6, 2018                                      
10: EX-10.48    Royalty Agreement Dated for Reference September 6,  HTML     39K 
                2018                                                             
11: EX-10.49    Letter of Intent Dated for Reference September 10,  HTML     34K 
                2018                                                             
 2: EX-21.1     List of Significant Subsidiaries                    HTML     24K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
18: R1          Document and Entity Information                     HTML     55K 
19: R2          Consolidated Balance Sheets                         HTML     81K 
20: R3          Balance Sheets (Parenthetical)                      HTML     35K 
21: R4          Consolidated Statements of Operations               HTML     72K 
22: R5          Consolidated Statements of Stockholders' Equity     HTML     76K 
                (Deficit)                                                        
23: R6          Consolidated Statements of Stockholders' Equity     HTML     28K 
                (Parenthetical)                                                  
24: R7          Consolidated Statements of Cash Flows               HTML    103K 
25: R8          Organization and Nature of Operations               HTML     31K 
26: R9          Summary of Significant Accounting Policies          HTML     45K 
27: R10         Related Party Transactions Disclosure               HTML     60K 
28: R11         Equipment Disclosure                                HTML     35K 
29: R12         Inventory Disclosure                                HTML     28K 
30: R13         Other Current Assets Disclosure                     HTML     28K 
31: R14         Unearned Revenue Disclosure                         HTML     30K 
32: R15         Notes and Advances Payable Disclosure               HTML     61K 
33: R16         Share Capital Disclosure                            HTML     74K 
34: R17         Income Taxes Disclosure                             HTML     50K 
35: R18         Subsequent Event Disclosure                         HTML     32K 
36: R19         Organization and Nature of Operations: Going        HTML     29K 
                Concern (Policies)                                               
37: R20         Summary of Significant Accounting Policies: Basis   HTML     28K 
                of Presentation (Policies)                                       
38: R21         Summary of Significant Accounting Policies:         HTML     30K 
                Principles of Consolidation, Policy (Policies)                   
39: R22         Summary of Significant Accounting Policies:         HTML     28K 
                Reclassifications, Policy (Policies)                             
40: R23         Summary of Significant Accounting Policies:         HTML     30K 
                Accounting Estimates, Policy (Policies)                          
41: R24         Summary of Significant Accounting Policies:         HTML     30K 
                Foreign Currency Translations and Transactions,                  
                Policy (Policies)                                                
42: R25         Summary of Significant Accounting Policies:         HTML     30K 
                Revenue Recognition, Policy (Policies)                           
43: R26         Summary of Significant Accounting Policies:         HTML     29K 
                Inventory Valuation, Policy (Policies)                           
44: R27         Summary of Significant Accounting Policies:         HTML     29K 
                Research and Development Costs, Policy (Policies)                
45: R28         Summary of Significant Accounting Policies: Income  HTML     31K 
                Taxes, Policy (Policies)                                         
46: R29         Summary of Significant Accounting Policies: Loss    HTML     30K 
                Per Share, Policy (Policies)                                     
47: R30         Summary of Significant Accounting Policies:         HTML     30K 
                Long-lived Assets, Policy (Policies)                             
48: R31         Summary of Significant Accounting Policies:         HTML     29K 
                Equipment, Policy (Policies)                                     
49: R32         Summary of Significant Accounting Policies: Fair    HTML     30K 
                Value Measurements, Policy (Policies)                            
50: R33         Summary of Significant Accounting Policies: Stock   HTML     30K 
                Options and Other Stock-based Compensation, Policy               
                (Policies)                                                       
51: R34         Summary of Significant Accounting Policies: Recent  HTML     28K 
                Accounting Pronouncements (Policies)                             
52: R35         Related Party Transactions Disclosure: Schedule of  HTML     38K 
                Amounts Due to Related Parties (Tables)                          
53: R36         Related Party Transactions Disclosure: Schedule of  HTML     44K 
                Transactions with Related Parties (Tables)                       
54: R37         Equipment Disclosure: Amortization Schedule for     HTML     35K 
                Equipment (Tables)                                               
55: R38         Notes and Advances Payable Disclosure: Schedule of  HTML     47K 
                Short-term Loans and Advances Outstanding (Tables)               
56: R39         Notes and Advances Payable Disclosure: Fair values  HTML     30K 
                assumptions of the warrants - Term Loan Agreement                
                (Tables)                                                         
57: R40         Share Capital Disclosure: Black-Scholes Option      HTML     30K 
                pricing valuation - Stock Options granted August                 
                24, 2017 (Tables)                                                
58: R41         Share Capital Disclosure: Schedule of Stock Option  HTML     44K 
                Activity (Tables)                                                
59: R42         Share Capital Disclosure: Schedule of Stock         HTML     33K 
                Options Outstanding (Tables)                                     
60: R43         Share Capital Disclosure: Schedule of Warrant       HTML     32K 
                Activity (Tables)                                                
61: R44         Share Capital Disclosure: Schedule of Warrant       HTML     38K 
                Details (Tables)                                                 
62: R45         Income Taxes Disclosure: Schedule of Effective      HTML     39K 
                Income Tax Rate Reconciliation (Tables)                          
63: R46         Income Taxes Disclosure: Schedule of Deferred Tax   HTML     36K 
                Assets and Liabilities (Tables)                                  
64: R47         Organization and Nature of Operations: Going        HTML     28K 
                Concern (Details)                                                
65: R48         Related Party Transactions Disclosure: Schedule of  HTML     39K 
                Amounts Due to Related Parties (Details)                         
66: R49         Related Party Transactions Disclosure: Schedule of  HTML     46K 
                Transactions with Related Parties (Details)                      
67: R50         Equipment Disclosure (Details)                      HTML     27K 
68: R51         Equipment Disclosure: Amortization Schedule for     HTML     36K 
                Equipment (Details)                                              
69: R52         Inventory Disclosure (Details)                      HTML     30K 
70: R53         Other Current Assets Disclosure (Details)           HTML     29K 
71: R54         Unearned Revenue Disclosure (Details)               HTML     35K 
72: R55         Notes and Advances Payable Disclosure: Schedule of  HTML     45K 
                Short-term Loans and Advances Outstanding                        
                (Details)                                                        
73: R56         Notes and Advances Payable Disclosure (Details)     HTML     49K 
74: R57         Share Capital Disclosure (Details)                  HTML     27K 
75: R58         Share Capital Disclosure: Schedule of Stock Option  HTML     39K 
                Activity (Details)                                               
76: R59         Share Capital Disclosure: Schedule of Stock         HTML     37K 
                Options Outstanding (Details)                                    
77: R60         Share Capital Disclosure: Schedule of Warrant       HTML     30K 
                Activity (Details)                                               
78: R61         Share Capital Disclosure: Schedule of Warrant       HTML     32K 
                Details (Details)                                                
79: R62         Income Taxes Disclosure: Schedule of Effective      HTML     44K 
                Income Tax Rate Reconciliation (Details)                         
80: R63         Income Taxes Disclosure: Schedule of Deferred Tax   HTML     33K 
                Assets and Liabilities (Details)                                 
81: R64         Income Taxes Disclosure (Details)                   HTML     30K 
82: R65         Subsequent Event Disclosure (Details)               HTML     32K 
84: XML         IDEA XML File -- Filing Summary                      XML    154K 
83: EXCEL       IDEA Workbook of Financial Reports                  XLSX     63K 
12: EX-101.INS  XBRL Instance -- cmxc-20180531                       XML    634K 
14: EX-101.CAL  XBRL Calculations -- cmxc-20180531_cal               XML     50K 
15: EX-101.DEF  XBRL Definitions -- cmxc-20180531_def                XML    247K 
16: EX-101.LAB  XBRL Labels -- cmxc-20180531_lab                     XML    484K 
17: EX-101.PRE  XBRL Presentations -- cmxc-20180531_pre              XML    453K 
13: EX-101.SCH  XBRL Schema -- cmxc-20180531                         XSD    143K 
85: ZIP         XBRL Zipped Folder -- 0001393905-18-000275-xbrl      Zip     69K

‘EX-101.PRE’ — XBRL Presentations — cmxc-20180531_pre

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:fil="http://www.cellmedx.com/20180531" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance">

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DocumentDocumentAndEntityInformation"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DocumentDocumentAndEntityInformation">

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DocumentAndEntityInformationAbstract" xlink:label="fil_DocumentAndEntityInformationAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="fil_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_ConsolidatedBalanceSheets"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_ConsolidatedBalanceSheets">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:label="us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_Reserves" xlink:label="fil_Reserves"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_BalanceSheetsParenthetical" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_BalanceSheetsParenthetical"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_BalanceSheetsParenthetical">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_ConsolidatedStatementsOfOperations"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfOperations">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenuesAbstract" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_SalesRevenueNet" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="us-gaap_ProfessionalAndContractServicesExpense"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalAndContractServicesExpense" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherExpensesAbstract" xlink:label="us-gaap_OtherExpensesAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherExpensesAbstract" xlink:to="us-gaap_AccretionExpense" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_ConsolidatedStatementsOfStockholdersEquityDeficit"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfStockholdersEquityDeficit">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ObligationToIssueSharesMember" xlink:label="fil_ObligationToIssueSharesMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="fil_ObligationToIssueSharesMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReserveForOffBalanceSheetActivitiesMember" xlink:label="us-gaap_ReserveForOffBalanceSheetActivitiesMember"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestAndDebtExpense" xlink:label="us-gaap_InterestAndDebtExpense"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:label="us-gaap_GainOrLossOnSaleOfStockInSubsidiary"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" use="optional" order="12.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_UnitsIssuedOnConversionOfDepositsShares" xlink:label="fil_UnitsIssuedOnConversionOfDepositsShares"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_UnitsIssuedOnConversionOfDepositsValue" xlink:label="fil_UnitsIssuedOnConversionOfDepositsValue"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax" xlink:label="us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax" use="optional" order="16.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" use="optional" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_1"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_1" use="optional" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_1"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_1" use="optional" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_ConsolidatedStatementsOfStockholdersEquityParenthetical"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfStockholdersEquityParenthetical">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:label="us-gaap_StockTransactionsParentheticalDisclosuresAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:to="us-gaap_StatementTable" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ForTechnologyMember" xlink:label="fil_ForTechnologyMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="fil_ForTechnologyMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ForConsultingFeesMember" xlink:label="fil_ForConsultingFeesMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="fil_ForConsultingFeesMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_ConsolidatedStatementsOfCashFlows"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_ConsolidatedStatementsOfCashFlows">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentForAmortization" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet" use="optional" order="2.0"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="us-gaap_OtherNoncashExpense"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_FinancingFeesNoncash" xlink:label="fil_FinancingFeesNoncash"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="fil_FinancingFeesNoncash" use="optional" order="5.0"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" use="optional" order="6.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedLossOnForeignCurrencyDerivativesBeforeTax" xlink:label="us-gaap_UnrealizedLossOnForeignCurrencyDerivativesBeforeTax"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_UnrealizedLossOnForeignCurrencyDerivativesBeforeTax" use="optional" order="7.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ResearchAndDevelopmentNoncash" xlink:label="fil_ResearchAndDevelopmentNoncash"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="fil_ResearchAndDevelopmentNoncash" use="optional" order="8.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" use="optional" order="6.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfDebt" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:label="us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" use="optional" order="7.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" use="optional" order="8.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_1" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" use="optional" order="11.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_UnitsIssuedOnConversionOfDepositsValue" xlink:label="fil_UnitsIssuedOnConversionOfDepositsValue"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="fil_UnitsIssuedOnConversionOfDepositsValue" use="optional" order="2.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureOrganizationAndNatureOfOperations" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureOrganizationAndNatureOfOperations"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureOrganizationAndNatureOfOperations">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureRelatedPartyTransactionsDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureEquipmentDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureInventoryDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureInventoryDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureInventoryDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureOtherCurrentAssetsDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureOtherCurrentAssetsDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureOtherCurrentAssetsDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureUnearnedRevenueDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureUnearnedRevenueDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureUnearnedRevenueDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureNotesAndAdvancesPayableDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureIncomeTaxesDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSubsequentEventDisclosure" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSubsequentEventDisclosure"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSubsequentEventDisclosure">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureOrganizationAndNatureOfOperationsGoingConcernPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureOrganizationAndNatureOfOperationsGoingConcernPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureOrganizationAndNatureOfOperationsGoingConcernPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesReclassificationsPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesReclassificationsPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesReclassificationsPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesForeignCurrencyTranslationsAndTransactionsPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesForeignCurrencyTranslationsAndTransactionsPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesForeignCurrencyTranslationsAndTransactionsPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesInventoryValuationPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesInventoryValuationPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesInventoryValuationPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesResearchAndDevelopmentCostsPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesResearchAndDevelopmentCostsPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesResearchAndDevelopmentCostsPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesLossPerSharePolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesLossPerSharePolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesLossPerSharePolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesEquipmentPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesEquipmentPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesEquipmentPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesFairValueMeasurementsPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesFairValueMeasurementsPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesFairValueMeasurementsPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesStockOptionsAndOtherStockBasedCompensationPolicyPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesStockOptionsAndOtherStockBasedCompensationPolicyPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesStockOptionsAndOtherStockBasedCompensationPolicyPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsPolicies"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsPolicies">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesTables">

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ScheduleOfExpensesWithRelatedPartiesTextBlock" xlink:label="fil_ScheduleOfExpensesWithRelatedPartiesTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="fil_ScheduleOfExpensesWithRelatedPartiesTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosureAmortizationScheduleForEquipmentTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureEquipmentDisclosureAmortizationScheduleForEquipmentTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosureAmortizationScheduleForEquipmentTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfShortTermLoansAndAdvancesOutstandingTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfShortTermLoansAndAdvancesOutstandingTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfShortTermLoansAndAdvancesOutstandingTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureFairValuesAssumptionsOfTheWarrantsTermLoanAgreementTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureNotesAndAdvancesPayableDisclosureFairValuesAssumptionsOfTheWarrantsTermLoanAgreementTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureFairValuesAssumptionsOfTheWarrantsTermLoanAgreementTables">

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_FairValuesAssumptionsOfTheWarrantsTermLoanTextBlock" xlink:label="fil_FairValuesAssumptionsOfTheWarrantsTermLoanTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="fil_FairValuesAssumptionsOfTheWarrantsTermLoanTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureBlackScholesOptionPricingValuationStockOptionsGrantedAugust242017Tables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureBlackScholesOptionPricingValuationStockOptionsGrantedAugust242017Tables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureBlackScholesOptionPricingValuationStockOptionsGrantedAugust242017Tables">

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_VendortechstockoptionsvalueTextBlock" xlink:label="fil_VendortechstockoptionsvalueTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="fil_VendortechstockoptionsvalueTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionsOutstandingTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionsOutstandingTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionsOutstandingTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityTables">

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ContinuityScheduleOfWarrantsTextBlock" xlink:label="fil_ContinuityScheduleOfWarrantsTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="fil_ContinuityScheduleOfWarrantsTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfEffectiveIncomeTaxRateReconciliationTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureIncomeTaxesDisclosureScheduleOfEffectiveIncomeTaxRateReconciliationTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfEffectiveIncomeTaxRateReconciliationTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesTables" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureIncomeTaxesDisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesTables"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesTables">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" use="optional" order="1.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureOrganizationAndNatureOfOperationsGoingConcernDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureOrganizationAndNatureOfOperationsGoingConcernDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureOrganizationAndNatureOfOperationsGoingConcernDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DueToTheFormerCeoAndDirectorMember" xlink:label="fil_DueToTheFormerCeoAndDirectorMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_DueToTheFormerCeoAndDirectorMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DueToADirectorAndFormerCeoAndPresidentMember" xlink:label="fil_DueToADirectorAndFormerCeoAndPresidentMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_DueToADirectorAndFormerCeoAndPresidentMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DueToTheCFOMember" xlink:label="fil_DueToTheCFOMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_DueToTheCFOMember" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DueToTheVpOfTechnologyAndOperationsMember" xlink:label="fil_DueToTheVpOfTechnologyAndOperationsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_DueToTheVpOfTechnologyAndOperationsMember" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DueToTheChiefMedicalOfficerMember" xlink:label="fil_DueToTheChiefMedicalOfficerMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_DueToTheChiefMedicalOfficerMember" use="optional" order="6.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DueToTheFormerVpCorporateStrategyMember" xlink:label="fil_DueToTheFormerVpCorporateStrategyMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_DueToTheFormerVpCorporateStrategyMember" use="optional" order="7.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ManagementFeesIncurredToTheFormerCeoAndDirectorMember" xlink:label="fil_ManagementFeesIncurredToTheFormerCeoAndDirectorMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_ManagementFeesIncurredToTheFormerCeoAndDirectorMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ManagementFeesIncurredToADirectorAndFormerCeoAndPresidentMember" xlink:label="fil_ManagementFeesIncurredToADirectorAndFormerCeoAndPresidentMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_ManagementFeesIncurredToADirectorAndFormerCeoAndPresidentMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_StockBasedCompensationIncurredToTheDirectorAndFormerCeoAndPresidentMember" xlink:label="fil_StockBasedCompensationIncurredToTheDirectorAndFormerCeoAndPresidentMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_StockBasedCompensationIncurredToTheDirectorAndFormerCeoAndPresidentMember" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ManagementFeesIncurredToTheCfoMember" xlink:label="fil_ManagementFeesIncurredToTheCfoMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_ManagementFeesIncurredToTheCfoMember" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_StockBasedCompensationIncurredToTheCfoMember" xlink:label="fil_StockBasedCompensationIncurredToTheCfoMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_StockBasedCompensationIncurredToTheCfoMember" use="optional" order="6.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ConsultingFeesIncurredToTheFormerVpCorporateStrategyMember" xlink:label="fil_ConsultingFeesIncurredToTheFormerVpCorporateStrategyMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_ConsultingFeesIncurredToTheFormerVpCorporateStrategyMember" use="optional" order="7.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ConsultingFeesIncurredToTheVpTechnologyAndOperationsMember" xlink:label="fil_ConsultingFeesIncurredToTheVpTechnologyAndOperationsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_ConsultingFeesIncurredToTheVpTechnologyAndOperationsMember" use="optional" order="8.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_StockBasedCompensationIncurredToTheChiefMedicalOfficerMember" xlink:label="fil_StockBasedCompensationIncurredToTheChiefMedicalOfficerMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_StockBasedCompensationIncurredToTheChiefMedicalOfficerMember" use="optional" order="9.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_AccruedInterestExpenseIncurredToASignificantShareholderMember" xlink:label="fil_AccruedInterestExpenseIncurredToASignificantShareholderMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_AccruedInterestExpenseIncurredToASignificantShareholderMember" use="optional" order="10.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_AccretionExpenseLoanSignificantShareholderMember" xlink:label="fil_AccretionExpenseLoanSignificantShareholderMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="fil_AccretionExpenseLoanSignificantShareholderMember" use="optional" order="11.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureEquipmentDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_EbalanceProWellnessDevicesMember" xlink:label="fil_EbalanceProWellnessDevicesMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="fil_EbalanceProWellnessDevicesMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:label="us-gaap_PaymentsToAcquireMachineryAndEquipment"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosureAmortizationScheduleForEquipmentDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureEquipmentDisclosureAmortizationScheduleForEquipmentDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureEquipmentDisclosureAmortizationScheduleForEquipmentDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions" xlink:label="us-gaap_PropertyPlantAndEquipmentAdditions"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAdditions" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" order="4.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureInventoryDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureInventoryDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureInventoryDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_SuppliesHeldForResaleMember" xlink:label="fil_SuppliesHeldForResaleMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="fil_SuppliesHeldForResaleMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_AttributedToWorkInProgressMember" xlink:label="fil_AttributedToWorkInProgressMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="fil_AttributedToWorkInProgressMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureOtherCurrentAssetsDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureOtherCurrentAssetsDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureOtherCurrentAssetsDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByAssetClassAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_PrepaidExpenseMember" xlink:label="fil_PrepaidExpenseMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="fil_PrepaidExpenseMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ReceivablesAssociatedWithGstMember" xlink:label="fil_ReceivablesAssociatedWithGstMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="fil_ReceivablesAssociatedWithGstMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureUnearnedRevenueDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureUnearnedRevenueDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureUnearnedRevenueDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DepositsFromCustomersDistributionContractsMember" xlink:label="fil_DepositsFromCustomersDistributionContractsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="fil_DepositsFromCustomersDistributionContractsMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DepositsFromCustomersEbalanceProDevicesMember" xlink:label="fil_DepositsFromCustomersEbalanceProDevicesMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="fil_DepositsFromCustomersEbalanceProDevicesMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DepositsFromItsCustomersMember" xlink:label="fil_DepositsFromItsCustomersMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="fil_DepositsFromItsCustomersMember" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromDepositsFromCustomers" xlink:label="us-gaap_ProceedsFromDepositsFromCustomers"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromDepositsFromCustomers" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_UnitsIssuedCSOnConversionOfDeposits" xlink:label="fil_UnitsIssuedCSOnConversionOfDeposits"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="fil_UnitsIssuedCSOnConversionOfDeposits" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfShortTermLoansAndAdvancesOutstandingDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfShortTermLoansAndAdvancesOutstandingDetails"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ShortTermLoan1Member" xlink:label="fil_ShortTermLoan1Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_ShortTermLoan1Member" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ShortTermLoan2Member" xlink:label="fil_ShortTermLoan2Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_ShortTermLoan2Member" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ShortTermLoan4Member" xlink:label="fil_ShortTermLoan4Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_ShortTermLoan4Member" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_ShortTermLoan3Member" xlink:label="fil_ShortTermLoan3Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_ShortTermLoan3Member" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureNotesAndAdvancesPayableDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureNotesAndAdvancesPayableDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_LoanAgreementsMrJeffsMember" xlink:label="fil_LoanAgreementsMrJeffsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_LoanAgreementsMrJeffsMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_LoanAgreementWithAnArmsLengthPartyMember" xlink:label="fil_LoanAgreementWithAnArmsLengthPartyMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_LoanAgreementWithAnArmsLengthPartyMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_LoanAgreementsMrJeffsAssignedToThirdPartyMember" xlink:label="fil_LoanAgreementsMrJeffsAssignedToThirdPartyMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_LoanAgreementsMrJeffsAssignedToThirdPartyMember" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DebtSettlementNotesPayableMember" xlink:label="fil_DebtSettlementNotesPayableMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_DebtSettlementNotesPayableMember" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_TermLoanAgreementMrJeffsMember" xlink:label="fil_TermLoanAgreementMrJeffsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_TermLoanAgreementMrJeffsMember" use="optional" order="6.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_DemandNotesPayableMrJeffsMember" xlink:label="fil_DemandNotesPayableMrJeffsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="fil_DemandNotesPayableMrJeffsMember" use="optional" order="7.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromOtherShortTermDebt" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" use="optional" order="5.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionsOutstandingDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionsOutstandingDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="us-gaap_ShareholdersEquityClassAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ShareholdersEquityClassAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="us-gaap_FairValueByShareholdersEquityClassDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="us-gaap_FairValueByShareholdersEquityClassDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_GrantedNovember252014Member" xlink:label="fil_GrantedNovember252014Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_GrantedNovember252014Member" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_OptionsGrantedJanuary132015Member" xlink:label="fil_OptionsGrantedJanuary132015Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_OptionsGrantedJanuary132015Member" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_OptionsGrantedAugust52015Member" xlink:label="fil_OptionsGrantedAugust52015Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_OptionsGrantedAugust52015Member" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_OptionsGrantedAugust242017CfoAndConsultantsMember" xlink:label="fil_OptionsGrantedAugust242017CfoAndConsultantsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_OptionsGrantedAugust242017CfoAndConsultantsMember" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" use="optional" order="2.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_WarrantsIssued" xlink:label="fil_WarrantsIssued"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ShareholdersEquityClassAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_WarrantsGrantedMarch32016Member" xlink:label="fil_WarrantsGrantedMarch32016Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_WarrantsGrantedMarch32016Member" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_WarrantsExpiringOctober122021Member" xlink:label="fil_WarrantsExpiringOctober122021Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_WarrantsExpiringOctober122021Member" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_WarrantsGrantedOctober122017Member" xlink:label="fil_WarrantsGrantedOctober122017Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_WarrantsGrantedOctober122017Member" use="optional" order="4.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_WarrantsGrantedFebruary72018Member" xlink:label="fil_WarrantsGrantedFebruary72018Member"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="fil_WarrantsGrantedFebruary72018Member" use="optional" order="5.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_NumberOfWarrantsExercisable" xlink:label="fil_NumberOfWarrantsExercisable"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureIncomeTaxesDisclosureScheduleOfEffectiveIncomeTaxRateReconciliationDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfEffectiveIncomeTaxRateReconciliationDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" use="optional" order="6.0"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureIncomeTaxesDisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureIncomeTaxesDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureIncomeTaxesDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>

</link:presentationLink>

<link:roleRef roleURI="http://www.cellmedx.com/20180531/role/idr_DisclosureSubsequentEventDisclosureDetails" xlink:type="simple" xlink:href="cmxc-20180531.xsd#idr_DisclosureSubsequentEventDisclosureDetails"/>

<link:presentationLink xlink:type="extended" xlink:role="http://www.cellmedx.com/20180531/role/idr_DisclosureSubsequentEventDisclosureDetails">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" order="1.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_LoanAgreementWithMrJeffsMember" xlink:label="fil_LoanAgreementWithMrJeffsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="fil_LoanAgreementWithMrJeffsMember" use="optional" order="2.0"/>

<link:loc xlink:type="locator" xlink:href="cmxc-20180531.xsd#fil_LetterOfIntentForWorldwideDistributionRightsMember" xlink:label="fil_LetterOfIntentForWorldwideDistributionRightsMember"/>

<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="fil_LetterOfIntentForWorldwideDistributionRightsMember" use="optional" order="3.0"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="us-gaap_CustomerAdvancesAndDeposits"/>

</link:presentationLink>

</link:linkbase>

20 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc
 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   424B3                  1:365K                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   10-Q        8/31/21   50:2.2M                                   Empire Stock Transf… Inc
10/12/21  Cell MedX Corp.                   424B3                  1:705K                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   424B3                  1:501K                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 3/04/21  Cell MedX Corp.                   S-1                   78:3.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
10/15/20  Cell MedX Corp.                   10-Q        8/31/20   51:1.9M                                   Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc

↑Top

Filing Submission 0001393905-18-000275 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Cell MedX Corp. – ‘10-K’ for 5/31/18 – ‘EX-101.PRE’

On: Thursday, 9/13/18, at 4:36pm ET · For: 5/31/18 · Accession #: 1393905-18-275 · File #: 0-54500

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘EX-101.PRE’ — XBRL Presentations — cmxc-20180531_pre

This Exhibit is an XBRL XML File.

20 Subsequent Filings that Reference this Filing

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents